{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:35:51Z","timestamp":1790238951892,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T00:00:00Z","timestamp":1263168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T00:00:00Z","timestamp":1263168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2010,3,25]]},"DOI":"10.1038\/onc.2009.470","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T06:19:13Z","timestamp":1263190753000},"page":"1741-1752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":162,"title":["Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes"],"prefix":"10.1038","volume":"29","author":[{"given":"K","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mandai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Oura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hamanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S K","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,11]]},"reference":[{"key":"BFonc2009470_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","volume":"1171","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C et al. (2009a). Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann NY Acad Sci 1171: 59\u201376.","journal-title":"Ann NY Acad Sci"},{"key":"BFonc2009470_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/1078-0432.CCR-08-0149","volume":"15","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Vijayalekshmi RV, Sung B . (2009b). Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 15: 425\u2013430.","journal-title":"Clin Cancer Res"},{"key":"BFonc2009470_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature04296","volume":"439","author":"AH Bild","year":"2006","unstructured":"Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D et al. (2006). Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353\u2013357.","journal-title":"Nature"},{"key":"BFonc2009470_CR4","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1158\/0008-5472.CAN-07-6595","volume":"68","author":"T Bonome","year":"2008","unstructured":"Bonome T, Levine DA, Shih J, Randonovich M, Pise-Masison CA, Bogomolniy F et al. (2008). A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res 68: 5478\u20135486.","journal-title":"Cancer Res"},{"key":"BFonc2009470_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0002-9378(97)70550-7","volume":"176","author":"LA Brinton","year":"1997","unstructured":"Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A . (1997). Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176: 572\u2013579.","journal-title":"Am J Obstet Gynecol"},{"key":"BFonc2009470_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1096\/fj.03-0660fje","volume":"18","author":"S Cattaruzza","year":"2004","unstructured":"Cattaruzza S, Schiappacassi M, Kimata K, Colombatti A, Perris R . (2004). The globular domains of PG-M\/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells. FASEB J 18: 779\u2013781.","journal-title":"FASEB J"},{"key":"BFonc2009470_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ygyno.2008.02.006","volume":"109","author":"JK Chan","year":"2008","unstructured":"Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS . (2008). Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 109: 370\u2013376.","journal-title":"Gynecol Oncol"},{"key":"BFonc2009470_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nm1230","volume":"11","author":"W Cheng","year":"2005","unstructured":"Cheng W, Liu J, Yoshida H, Rosen D, Naora H . (2005). Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat Med 11: 531\u2013537.","journal-title":"Nat Med"},{"key":"BFonc2009470_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nm1173","volume":"11","author":"DM Dinulescu","year":"2005","unstructured":"Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T . (2005). Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11: 63\u201370.","journal-title":"Nat Med"},{"key":"BFonc2009470_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/mc.20430","volume":"47","author":"R Garcia-Escudero","year":"2008","unstructured":"Garcia-Escudero R, Paramio JM . (2008). Gene expression profiling as a tool for basic analysis and clinical application of human cancer. Mol Carcinog 47: 573\u2013579.","journal-title":"Mol Carcinog"},{"key":"BFonc2009470_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrg2383","volume":"9","author":"G Gibson","year":"2008","unstructured":"Gibson G . (2008). The environmental contribution to gene expression profiles. Nat Rev Genet 9: 575\u2013581.","journal-title":"Nat Rev Genet"},{"key":"BFonc2009470_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL . (2002). Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38\u201347.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2009470_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1158\/1541-7786.MCR-08-0316","volume":"7","author":"VS Hawthorne","year":"2009","unstructured":"Hawthorne VS, Huang WC, Neal CL, Tseng LM, Hung MC, Yu D . (2009). ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells. Mol Cancer Res 7: 592\u2013600.","journal-title":"Mol Cancer Res"},{"key":"BFonc2009470_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/ng1297-384","volume":"17","author":"Y Horikawa","year":"1997","unstructured":"Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN et al. (1997). Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 17: 384\u2013385.","journal-title":"Nat Genet"},{"key":"BFonc2009470_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249\u2013264.","journal-title":"Biostatistics"},{"key":"BFonc2009470_CR16","first-page":"3573","volume":"61","author":"JP Issa","year":"2001","unstructured":"Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA . (2001). Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61: 3573\u20133577.","journal-title":"Cancer Res"},{"key":"BFonc2009470_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1349-7006.2008.00747.x","volume":"99","author":"H Itamochi","year":"2008","unstructured":"Itamochi H, Kigawa J, Terakawa N . (2008). Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci 99: 653\u2013658.","journal-title":"Cancer Sci"},{"key":"BFonc2009470_CR18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.juro.2007.05.012","volume":"178","author":"M Ito","year":"2007","unstructured":"Ito M, Nishiyama H, Kawanishi H, Matsui S, Guilford P, Reeve A et al. (2007). P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. J Urol 178: 1073\u20131079.","journal-title":"J Urol"},{"key":"BFonc2009470_CR19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1365-2559.2008.03006.x","volume":"52","author":"N Kato","year":"2008","unstructured":"Kato N, Motoyama T . (2008). Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression. Histopathology 52: 682\u2013688.","journal-title":"Histopathology"},{"key":"BFonc2009470_CR20","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-08-2127","volume":"15","author":"CK Lau","year":"2009","unstructured":"Lau CK, Yang ZF, Ho DW, Ng MN, Yeoh GC, Poon RT et al. (2009). An Akt\/hypoxia-inducible factor-1alpha\/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Clin Cancer Res 15: 3462\u20133471.","journal-title":"Clin Cancer Res"},{"key":"BFonc2009470_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ygyno.2007.03.041","volume":"106","author":"S Lee","year":"2007","unstructured":"Lee S, Garner EI, Welch WR, Berkowitz RS, Mok SC . (2007). Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma. Gynecol Oncol 106: 311\u2013317.","journal-title":"Gynecol Oncol"},{"key":"BFonc2009470_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/sj.bjc.6602662","volume":"93","author":"T Maeda","year":"2005","unstructured":"Maeda T, Tashiro H, Katabuchi H, Begum M, Ohtake H, Kiyono T et al. (2005). Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability. Br J Cancer 93: 116\u2013123.","journal-title":"Br J Cancer"},{"key":"BFonc2009470_CR23","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","volume":"11","author":"RT Marquez","year":"2005","unstructured":"Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M et al. (2005). Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11: 6116\u20136126.","journal-title":"Clin Cancer Res"},{"key":"BFonc2009470_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1214\/07-AOAS104","volume":"1","author":"MA Newton","year":"2007","unstructured":"Newton MA, Quintana FA, den Boon JA, Sengupta S, Ahlquist P . (2007). Random-set methods identify distinct aspects of the enrichment signal in gene-set analysis. Ann Appl Stat 1: 85\u2013106.","journal-title":"Ann Appl Stat"},{"key":"BFonc2009470_CR25","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.humpath.2007.02.010","volume":"38","author":"R Osada","year":"2007","unstructured":"Osada R, Horiuchi A, Kikuchi N, Yoshida J, Hayashi A, Ota M et al. (2007). Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. Hum Pathol 38: 1310\u20131320.","journal-title":"Hum Pathol"},{"key":"BFonc2009470_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. (2000). Molecular portraits of human breast tumours. Nature 406: 747\u2013752.","journal-title":"Nature"},{"key":"BFonc2009470_CR27","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1158\/0008-5472.CAN-06-3619","volume":"67","author":"D Pyeon","year":"2007","unstructured":"Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ et al. (2007). Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head\/neck and cervical cancers. Cancer Res 67: 4605\u20134619.","journal-title":"Cancer Res"},{"key":"BFonc2009470_CR28","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1200\/JCO.2002.20.7.1932","volume":"20","author":"S Ramaswamy","year":"2002","unstructured":"Ramaswamy S, Golub TR . (2002). DNA microarrays in clinical oncology. J Clin Oncol 20: 1932\u20131941.","journal-title":"J Clin Oncol"},{"key":"BFonc2009470_CR29","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1073\/pnas.0408105102","volume":"102","author":"R Sandberg","year":"2005","unstructured":"Sandberg R, Ernberg I . (2005). Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci USA 102: 2052\u20132057.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009470_CR30","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1091\/mbc.e03-05-0279","volume":"14","author":"ME Schaner","year":"2003","unstructured":"Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M et al. (2003). Gene expression patterns in ovarian carcinomas. Mol Biol Cell 14: 4376\u20134386.","journal-title":"Mol Biol Cell"},{"key":"BFonc2009470_CR31","first-page":"4722","volume":"62","author":"DR Schwartz","year":"2002","unstructured":"Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM et al. (2002). Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 62: 4722\u20134729.","journal-title":"Cancer Res"},{"key":"BFonc2009470_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<669::AID-CNCR17>3.0.CO;2-F","volume":"85","author":"M Shimizu","year":"1999","unstructured":"Shimizu M, Nikaido T, Toki T, Shiozawa T, Fujii S . (1999). Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas. Cancer 85: 669\u2013677.","journal-title":"Cancer"},{"key":"BFonc2009470_CR33","first-page":"177","volume":"26","author":"I Skirnisdottir","year":"2005","unstructured":"Skirnisdottir I, Seidal T, Karlsson MG, Sorbe B . (2005). Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II. Int J Oncol 26: 177\u2013183.","journal-title":"Int J Oncol"},{"key":"BFonc2009470_CR34","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545\u201315550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009470_CR35","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","volume":"88","author":"T Sugiyama","year":"2000","unstructured":"Sugiyama T, Kamura T, Kigawa J, Terakawa N, Kikuchi Y, Kita T et al. (2000). Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88: 2584\u20132589.","journal-title":"Cancer"},{"key":"BFonc2009470_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ng1490","volume":"37","author":"A Sweet-Cordero","year":"2005","unstructured":"Sweet-Cordero A, Mukherjee S, Subramanian A, You H, Roix JJ, Ladd-Acosta C et al. (2005). An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat Genet 37: 48\u201355.","journal-title":"Nat Genet"},{"key":"BFonc2009470_CR37","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.bjc.6603116","volume":"94","author":"M Takano","year":"2006","unstructured":"Takano M, Kikuchi Y, Yaegashi N, Kuzuya K, Ueki M, Tsuda H et al. (2006). Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer 94: 1369\u20131374.","journal-title":"Br J Cancer"},{"key":"BFonc2009470_CR38","doi-asserted-by":"publisher","first-page":"7418","DOI":"10.1158\/1078-0432.CCR-04-0279","volume":"10","author":"Y Takemoto","year":"2004","unstructured":"Takemoto Y, Yano H, Momosaki S, Ogasawara S, Nishida N, Kojiro S et al. (2004). Antiproliferative effects of interferon-alphaCon1 on ovarian clear cell adenocarcinoma in vitro and in vivo. Clin Cancer Res 10: 7418\u20137426.","journal-title":"Clin Cancer Res"},{"key":"BFonc2009470_CR39","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/S0002-9440(10)63605-X","volume":"163","author":"A Tsuchiya","year":"2003","unstructured":"Tsuchiya A, Sakamoto M, Yasuda J, Chuma M, Ohta T, Ohki M et al. (2003). Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol 163: 2503\u20132512.","journal-title":"Am J Pathol"},{"key":"BFonc2009470_CR40","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G . (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116\u20135121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009470_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc1571","volume":"5","author":"T Ushijima","year":"2005","unstructured":"Ushijima T . (2005). Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5: 223\u2013231.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2009470_CR42","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van 't Veer","year":"2002","unstructured":"van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530\u2013536.","journal-title":"Nature"},{"key":"BFonc2009470_CR43","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1093\/nar\/25.12.2532","volume":"25","author":"Z Xiong","year":"1997","unstructured":"Xiong Z, Laird PW . (1997). COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25: 2532\u20132534.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2009470_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/1078-0432.CCR-07-1614","volume":"14","author":"K Yamaguchi","year":"2008","unstructured":"Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K et al. (2008). Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res 14: 32\u201340.","journal-title":"Clin Cancer Res"},{"key":"BFonc2009470_CR45","first-page":"RA78","volume":"14","author":"M Zaffanello","year":"2008","unstructured":"Zaffanello M, Brugnara M, Franchini M, Fanos V . (2008). TCF2 gene mutation leads to nephro-urological defects of unequal severity: an open question. Med Sci Monit 14: RA78\u2013RA86.","journal-title":"Med Sci Monit"},{"key":"BFonc2009470_CR46","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.1158\/1078-0432.CCR-05-0508","volume":"11","author":"KK Zorn","year":"2005","unstructured":"Zorn KK, Bonome T, Gangi L, Chandramouli GV, Awtrey CS, Gardner GJ et al. (2005). Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res 11: 6422\u20136430.","journal-title":"Clin Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2009470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009470","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T13:49:24Z","timestamp":1647870564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2009470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,11]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,3,25]]}},"alternative-id":["BFonc2009470"],"URL":"https:\/\/doi.org\/10.1038\/onc.2009.470","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,11]]},"assertion":[{"value":"24 September 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}